Neurofibromatosis type 1-associated unusual pleomorphic astrocytoma displaying continual malignant progression

Pathology International

Volumn 51, Issue 7, 2001, Pages 570-577

  Yokoo, Hideaki ^a   Kamiya, Makoto ^a   Sasaki, Atsushi ^a   Hirato, Junko ^a   Nakazato, Yoichi ^a   Kurachi, Hiroshi ^b  

^a GUNMA UNIVERSITY   (Japan)

^b National Hospital Organization   (Japan)

Author keywords

Astrocytoma; Immunohistochemistry; Neurofibromatosis type 1; Rosenthal fiber; Ultrastructure; Von Recklinghausen's disease

Indexed keywords

KI 67 ANTIGEN; PROCARBAZINE; PROTEIN P27; PROTEIN P53; RANIMUSTINE; VINCRISTINE;

ADOLESCENT; ARTICLE; ASTROCYTOMA; CANCER GROWTH; CASE REPORT; CELL ULTRASTRUCTURE; CLINICAL EXAMINATION; CRANIOTOMY; DISEASE ASSOCIATION; ELECTRON MICROSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; NEUROFIBROMATOSIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM;

ADOLESCENT; ANTIGENS, NUCLEAR; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASTROCYTOMA; CEREBRAL VENTRICLE NEOPLASMS; DNA PRIMERS; DNA, NEOPLASM; FATAL OUTCOME; FEMALE; HUMANS; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; NEUROFIBROMATOSIS 1; NITROSOUREA COMPOUNDS; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROCARBAZINE; THALAMUS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; VINCRISTINE;

EID: 0034880329     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2001.01237.x     Document Type: Article

References (54)

1. Neurofibromatosis. Conference statement
2. Epidemiology of neurofibromatosis type 1
3. Glioma in neurofibromatosis: A series of 89 cases with evidence for enhanced malignancy in associated cerebellar astrocytomas
4. Von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata
5. Brain tumors in children with von Recklinghausen neurofibromatosis
6. Optic gliomas in children with neurofibromatosis type 1
7. Neurological complications of neurofibromatosis type 1 in adulthood
8. Genetic alterations associated with the evolution and progression of astrocytic brain tumors
9. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas
10. Prognostic factors in pediatric brain-stem gliomas
11. Localization of S-100 protein and glial fibrillary acidic protein-related antigen in pleomorphic adenoma of the salivary glands
12. Immunohistochemical localization of neurofilament protein in neuronal degenerations
13. αB-crystallin is expressed in non-lenticular tissues and accumulates in Alexander's disease brain
14. p53 gene mutations in oropharyngeal carcinomas: A comparison of solitary and multiple primary tumours and lymph-node metastases
15. Rosenthal fibres: An immunohistochemical, ultrastructural and immunoelectron microscopic study
16. Immunocytochemical and ultrastructural studies of eosinophilic granular bodies in astrocytic tumors
17. Natural history of optic pathway tumors in children with neurofibromatosis type 1: A longitudinal study
18. Spontaneous regression of optic glioma in a patient with neurofibromatosis
19. Spontaneous involution of optic pathway lesions in neurofibromatosis type 1: Serial contrast MR evaluation
20. Spontaneous decrease of a pilocytic astrocytoma in neurofibromatosis type 1
21. Spontaneous remission of chiasmatic/hypothalamic masses in neurofibromatosis type 1: Report of two cases
22. Malignant evolution of presumed benign lesions in the brain in neurofibromatosis: Case report
23. Pleomorphic xanthoastrocytoma associated with von Reckling-hausen neurofibromatosis
24. Pleomorphic xanthoastrocytoma with neurofibromatosis type 1: Case report
25. Malignant evolution of childhood chiasmal pilocytic astrocytoma
26. Anaplastic evolution of childhood optico-hypothalamic pilocytic astrocytoma: Report of an autopsy case
27. Molecular genetic alterations in pleomorphic xanthoastrocytoma
28. Fatal pleomorphic xanthoastrocytoma with meningeal gliomatosis
29. Anaplastic pleomorphic xanthoastrocytoma
30. Pleomorphic xanthoastrocytoma. What do we really know about it?
31. Successful chemotherapy for recurrent malignant oligodendroglioma
32. Aggressive oligodendroglioma. A chemosensitive tumor
33. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis
34. Formation of p27-CDK complexes during the human mitotic cell cycle
35. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
36. Kip1 accumulation during the cell cycle
37. p27/kip1 expression in human astrocytic gliomas
38. Proteasome-dependent degradation of p27/kip1 in gliomas
39. kip1 expression in a subset of malignant gliomas
40. Cerebral granular cell tumor: Immunohistochemical and electron microscopic study
41. Granular cell glioblastoma: A malignant granular cell neoplasm of astrocytic origin
42. Degenerative cellular structures in gliomas
43. Histological, immunohistochemical and electron microscopic studies on degenerative structures (Rosenthal fibers, rounded granular corpuscles and hyaline inclusions) in gliomas
44. Cytoplasmic inclusions of astrocytic elements of glial tumors: Special reference to round granulated body and eosinophilic hyaline droplets
45. Rosenthal fibers producing a granular cell appearance in a glioblastoma
46. Eosinophilic granular cells in oligodendrogliomas. An ultrastructural study
47. Evaluation of malignant features in oligodendroglial tumors
48. Characterisation of refractile eosinophilic granular cells in oligodendroglial tumors
49. Preferential expression of αB-crystallin in astrocytic elements of neuroectodermal tumors
50. Accumulation of αB-crystallin in central nervous system glia and neurons in pathologic conditions
51. αB-crystallin and 27-kd heat shock protein are regulated by stress conditions in the central nervous system and accumulate in Rosenthal fibers
52. Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice